Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study

Abstract The therapeutic options for disease modification in relapsing-remitting multiple sclerosis (RRMS) have expanded remarkably in the last 15 years. Although intravenous immunoglobulins (IVIg) have shown some therapeutic effects in multiple sclerosis, reducing global supplies, restriction of tr...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Srishti Gupta, Mohnish Suri, Cris S. Constantinescu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Adis, Springer Healthcare 2020-08-01
Ráidu:	Neurology and Therapy
Fáttát:	Ehlers-Danlos syndrome IVIg Muir-Torre syndrome Multiple sclerosis
Liŋkkat:	https://doi.org/10.1007/s40120-020-00209-0
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!